as on October 29, 2025 at 1:29 am IST
Day's Low
Day's High
13.27%
Downside
2.41%
Upside
52 Week's Low
52 Week's High
56.45%
Downside
10.25%
Upside
Check Precision Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$79.2M
EPS (TTM)
-7.9
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
4.5
Industry PE ratio
-2.817555555555556
PEG Ratio
0EBITDA
-88.2M
Revenue (TTM)
1.3M
Profit Margin
0.00%
Return On Equity TTM
-143.89%
Track how Precision Biosciences Inc P/E has moved over time to understand its valuation trends.
Precision Biosciences Inc in the last 5 years
Lowest (-184.25x)
March 31, 2021
Industry (-2.82x)
October 28, 2025
Today (4.50x)
October 28, 2025
Highest (61.99x)
June 30, 2024
Today’s Price to Earnings Ratio: 4.50x
Compare market cap, revenue, PE, and other key metrics of Precision Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $79.2M | -96.33% | 4.5 | 0.00% |
The Precision Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Precision Biosciences Inc investment value today
Current value as on today
₹1,05,252
Returns
₹5,252
(+5.25%)
Returns from Precision Biosciences Inc Stock
₹121 (+0.12%)
Dollar Returns*
₹5,132 (+5.13%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Precision Biosciences Inc. Average target price of $36.33
Get share price movements and forecasts by analysts on Precision Biosciences Inc.
What analysts predicted
77.18%UPSIDE
Target Price
$36.33
Current Price
$8.29
Analyzed by
12 Analysts
Target
$36.33
Precision Biosciences Inc target price $36.33, a slight upside of 77.18% compared to current price of $8.29. According to 12 analysts rating.
Search interest for Precision Biosciences Inc Stock has increased by 96% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:96% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 07 October
Tue, 07:22 PM
-Precision BioSciences opens first U.S. clinical trial site for the Eliminate-B trial, focusing on gene editing therapies.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 83.48 Cr → 116.51 Cr (in ₹), with an average increase of 28.4% per quarter
Retail Holding Up
![]()
Retail Investor have increased holdings from 29.09% to 29.11% in Sep 2025 quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -42.12 Cr → 14.35 Cr (in ₹), with an average increase of 393.5% per quarter
Price Rise
![]()
In the last 1 month, DTIL stock has moved up by 41.1%
Against Peers
![]()
In the last 3 years, Kaveri Seed Company Ltd has given 118.5% return, outperforming this stock by 135.1%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 80.1%
Against Peers
![]()
In the last 1 year, Avanti Feeds Ltd has given 27.9% return, outperforming this stock by 64.3%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 68.90% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 134.0% return, outperforming this stock by 217.1%
Profit Down
![]()
Netprofit is down for the last 5 quarters, 32.74M → -23.52M (in $), with an average decrease of 47.1% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 0.02% to 0.00% in Sep 2025 quarter
Price Dip
![]()
In the last 1 month, DTIL stock has moved down by -11.5%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 638.0K → 18.0K (in $), with an average decrease of 66.7% per quarter
| Organisation | Precision Biosciences Inc |
| Headquarters | 302 East Pettigrew St., Durham, NC, United States, 27701 |
| Industry | Biotechnology |
| CEO | Mr. Michael Amoroso |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. John Alexander Kelly R.Ph. | CFO & Principal Accounting Officer |
Mr. Naresh Tanna | Chief of Staff to CEO & Head of Investor Relations |
Ms. Cindy Atwell | Chief Development & Business Officer |
Mr. Neil Leatherbury M.S. | Senior VP and Head of Chemistry, Manufacturing & Controls |
Mr. Michael Amoroso | President, CEO & Director |
Dr. Jefferson J. Smith Ph.D. | Co-Founder & Chief Research Officer |
Dr. Cassie Gorsuch Ph.D. | Chief Scientific Officer |
Mr. Dario Scimeca J.D. | General Counsel & Secretary |
Ms. Juli Blanche | Chief People Officer |
Precision Biosciences Inc share price today is $8.29 as on at the close of the market. Precision Biosciences Inc share today touched a day high of $8.49 and a low of $7.19.
Precision Biosciences Inc share touched a 52 week high of $9.14 on and a 52 week low of $3.61 on . Precision Biosciences Inc stock price today i.e. is closed at $8.29,which is 9.30% down from its 52 week high and 129.64% up from its 52 week low.
Precision Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Precision Biosciences Inc (DTIL) shares with as little as ₹88.237 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.37 in Precision Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Precision Biosciences Inc share’s latest price of $8.29 as on October 29, 2025 at 1:29 am IST, you will get 1.2063 shares of Precision Biosciences Inc. Learn more about
fractional shares .
Precision Biosciences Inc stock has given -96.33% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?